Amongst such immune populations, γδ T cells are known to contribute to protective responses because of their potent ability to kill tumor cells and to produce cytokines like interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) [1–5], which constitutes a solid basis for γδ T-cell–based cancer immunotherapy strategies [6]. This evidence concerns the gene TNF and cancer.